Braskem Reports Strong Q1 Recurring EBITDA Growth Amid Volatile Market Conditions
Braskem (NYSE:BAK) reported a 76% sequential increase in recurring EBITDA to $192 million for the first quarter of 2026, driven by improved performance in Brazil and parts of Europe. However, Mexico's operations weakened due to lower ethane supply. The company faces high leverage at 16.81x and is focusing on cash preservation and capital structure discussions.
Tickers: $RKLB
Topics: cash_flow debt_management ebitda petrochemicals